Funda Meric-Bernstam

4 articles listing Funda Meric-Bernstam in Nature Communications, Nature, indexed by Paperzzz from Crossref and OSF.

1. Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial Nature Communications
2. How effective is the personalized off-label use of targeted cancer treatment? Nature
3. CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction Nature Communications
4. Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples Nature Communications